Yüklüyor......
Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine
BACKGROUND: Sustained pain freedom is an important attribute of acute migraine therapies for patients and physicians. Here we report efficacy of the centrally penetrant, highly selective, 5-HT(1F) agonist lasmiditan on sustained pain freedom and other outcomes at 24 and 48 hours post-dose. STUDY DES...
Kaydedildi:
| Yayımlandı: | Cephalalgia |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791026/ https://ncbi.nlm.nih.gov/pubmed/31266353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0333102419859313 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|